Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss conditions often have more mental health issues like depression and anxiety compared to those without hair loss.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

Non-daily contraceptives cause fewer side effects and are more satisfying to women, and certain oral contraceptives can treat acne and seborrhoea, with a combination of chlormadinone acetate and ethinyl estradiol being highly effective and safe.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Hair loss from mood stabilizers is common but can be managed without stopping the medication.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

Finasteride may affect mood and increase suicidal risk.

Patients on mood stabilizers need regular health checks, but many aren't monitored properly.

Dutasteride and finasteride do not increase mood disorder risk in men with hair loss.

Attractive women slightly worsened mood, green backgrounds improved mood, and older people had better moods.

A hair test shows promise for early mood disorder diagnosis.

Early puberty in girls leads to intense moods, restlessness, and greater self-certainty.

Higher cortisol and cortisone levels in hair may predict mood disorders after a stroke.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Vitamin D supplements improve bone pain, tiredness, hair loss, and mood, especially in women and older adults.

Most adult chronic hair pullers are women who started in their early teens, often have other mental health issues, and may pull hair due to underlying psychiatric conditions.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Some psychiatric medications can cause hair loss, but stopping or reducing the dose usually reverses it.

A comprehensive approach to educating patients and managing side effects is crucial for improving adherence to multiple sclerosis treatments and patient quality of life.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

The document explains various skin conditions in cats and how to diagnose and treat them.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and inhaled budesonide.

Valproic acid can cause a skin condition called leukocytoclastic vasculitis, which usually gets better after stopping the drug.

The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.